EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance lanreotide, ATC H01CB03 for the period 01.04.2026 - 31.03.2027 (plus extension option 1x12 months)
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lanreotid, ATC H01CB03 für die Zeit 01.04.2026 - 31.03.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Wanted: Pharmaceutical products. The tender is called “Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance lanreotide, ATC H01CB03 for the period 01.04.2026 - 31.03.2027 (plus extension option 1x12 months)”. The deadline for offers is Saturday, 5 February 2028, in 461 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 February 2028, 461 days left, 12:00
- Published
- 18 February 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
DAK-Gesundheit is concluding a discount agreement for the medicinal product lanreotide.
- The agreement is valid from 1 April 2026 to 31 March 2027 with an extension option.
- All pharmaceutical companies can join at any time under the same conditions.
- The complete documents must be submitted by email.
- For joining, the documents must be received by the 5th of the preceding month.
- The contract ends automatically in the event of a later exclusive contract.
Summary made from the German notice and checked against it; the German original is authoritative.
What stands out
The notice links the tender documents directly. The contract runs for 12 months.
Deadlines and dates
| Published | Wednesday, 18 February 2026 |
|---|---|
| Deadline | Saturday, 5 February 2028, 12:00 |
| Tender validity ends (calculated) | Monday, 6 March 2028 |
What the notice sets
| Duration | 12 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Service by CPV code
- 33600000 Pharmaceutical products
Questions and answers
When is the deadline for offers?
Until Saturday, 5 February 2028, 461 days left. The exact time and how to submit are in the original notice, which is authoritative.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.